Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
When you start peptide therapy, you might see results in just a few weeks
Novo Nordisk currently dominates the market for GLP-1 medications used for weight loss, while Eli Lilly's weight loss drug is expected to receive approval soon
Do GLP-1 supplements actually work
Deanfield J, Verma S, Engelen L, et al
Please call 301-476-4799 for more information
MOUNJARO 7.5mg KwikPen is a single-patient-use, multi-dose pre-filled pen containing tirzepatide a synthetic dual GIP/GLP-1 receptor agonist developed by Eli Lilly and Company Limited at a strength of 7.5mg per 0.6ml dose.[3][4] In the U.S., MOUNJARO (tirzepatide) is indicated for type 2 diabetes in adults and pediatric patients aged 10 years and older
.png)
US$ 24.60
US$ 22.07
US$ 24.13
US$ 26.79
US$ 21.45
US$ 29.47
